Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Tocilizumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Tocilizumab (rch) [PDF, 930.95 KB]

AusPAR: Tocilizumab (rch) [Word, 772.87 KB]

Attachment: Product Information: Tocilizumab (rch) [PDF, 490.14 KB]

Attachment: Product Information: Tocilizumab (rch) [Word, 149.27 KB]

Attachment: Extract from Clinical Evaluation Report: Tocilizumab (rch) [PDF, 1.5 MB]

Attachment: Extract from Clinical Evaluation Report: Tocilizumab (rch) [Word, 1.52 MB]

Device/Product Name

Actemra

Active ingredients

Tocilizumab (rch)

AusPAR Date

29 September 2016

Published

13 October 2016

Submission Number

PM-2014-04309-1-3

Submission Type

Major variation (new dosage form, new dose, new strength and new route of administration)

Decision

Approved